1 Mishra S, Murphy L C, Nyomba B L, et al. Prohibitin: a potential target for new therapeutics. Trends Mol Med, 2005, 11: 192-197？？
[2]
2 Nijtmans L G, Artal S M, Grivell L A, et al. The mitochondrial PHB complex: roles in mitochondrial respiratory complex assembly, ageingand degenerative disease. Cell Mol Life Sci, 2002, 59: 143-155？？
[3]
3 Sharma A, Qadri A. Vi polysaccharide of Salmonella typhi targets the prohibitin family of molecules in intestinal epithelial cells andsuppresses early inflammatory responses. Proc Natl Acad Sci USA, 2004, 101: 17492-17497？？
[4]
4 Fusaro G, Dasgupta P, Rastogi S, et al. Prohibitin induces the transcriptional activity of p53 and is exported from the nucleus upon apoptotic signaling. J Biol Chem, 2003, 278: 47853-47861？？
[5]
5 Jang J S, Cho H Y, Lee Y J, et al. The differential proteome profile of stomach cancer: identification of the biomarker candidates. Oncol Res,2004, 14: 491-499
[6]
6 Mengwasser J, Piau A, Schlag P, et al. Differential immunization identifies PHB1/PHB2 as blood-borne tumor antigens. Oncogene, 2004,23: 7430-7435？？
[7]
7 Asamoto M, Cohen S M. Prohibitin gene is overexpressed but not mutated in rat bladder carcinomas and cell lines. Cancer Lett, 1994, 83:201-207？？
[8]
9 Seow T K, Ong S E, Liang R C, et al. Two-dimensional electrophoresis map of the human hepatocellular carcinoma cell line, HCC-M, andidentification of the separated proteins by mass spectrometry. Electrophoresis, 2000, 21: 1787-1813？？
[9]
10 Xu Z, Zhou X, Lu H, et al. Comparative glycoproteomics based on lectins affinity capture of N-linked glycoproteins from human Changliver cells and MHCC97-H cells. Proteomics, 2007, 7: 2358-2370？？
[10]
11 Lowry O H, Rosebrough N J, Farr A L, et al. Protein measurement with the Folin phenol reagent. J Biol Chem, 1951, 193: 265-275
[11]
12 Wu N, Zhang W, Yang Y, et al. Profilin 1 obtained by proteomic analysis in all-trans retinoic acid-treated hepatocarcinoma cell lines isinvolved in inhibition of cell proliferation and migration. Proteomics, 2006, 6: 6095-6106？？
[12]
13 Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J ImmunolMethods, 1983, 65: 55-63
[13]
14 Li Y, Tang Z Y, Ye S L, et al. Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinomacell line MHCC97. World J Gastroenterol, 2001, 7: 630-636
[14]
15 Tang Z Y, Sun F X, Tian J, et al. Metastatic human hepatocellular carcinoma models in nude mice and cell line with metastatic potential.World J Gastroenterol, 2001, 7: 597-601
[15]
16 Peng X, Mehta R, Wang S, et al. Prohibitin is a novel target gene of vitamin D involved in its antiproliferative action in breast cancer cells.Cancer Res, 2006, 66: 7361-7369？？
[16]
17 Williams K, Chubb C, Huberman E, et al. Analysis of differential protein expression in normal and neoplastic human breast epithelial celllines. Electrophoresis, 1998, 19: 333-343？？
[17]
18 Neal C P, Garcea G, Doucas H, et al. Molecular prognostic markers in resectable colorectal liver metastases: a systematic review. Eur JCancer, 2006, 42: 1728-1743？？
[18]
19 Rajalingam K, Wunder C, Brinkmann V, et al. Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration.Nat Cell Biol, 2005, 7: 837-843？？
[19]
8 Byrjalsen I, Mose Larsen P, Fey S J, et al. Two-dimensional gel analysis of human endometrial proteins: characterization of proteins withincreased expression in hyperplasia and adenocarcinoma. Mol Hum Reprod, 1999, 5: 748-756？？
